A new paradigm in the treatment of patients with diffuse large B-cell lymphoma, one of the most aggressive blood cancers

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

It is the first treatment in the last 30 years that represents a relative improvement of 38% in the overall survival of patients compared to standard treatment. The results of Phase III study ZUMA-7 ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Some regions of the human genome conside...

by Universitat de Barcelona

Many repetitive regions of the genome have been considered “junk DNA...

Photos Stream